Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$505.16 USD
-6.10 (-1.19%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $505.17 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$505.16 USD
-6.10 (-1.19%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $505.17 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
Zacks News
Will Elevance Health (ELV) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Humana (HUM) Brings Affordable MA Plan to U.S. Veterans
by Zacks Equity Research
Humana (HUM) ties up with USAA Life to develop a Medicare Advantage plan that transcends the VA system to fetch added healthcare benefits for veterans.
Elevance Health's (ELV) Low-Cost MA Plans to Widen U.S. Base
by Zacks Equity Research
Elevance Health (ELV) devises suitable Medicare Advantage plans containing supplemental benefits, which consumers can avail in the 2023 Annual Enrollment Period.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks.com featured highlights include BJ's Wholesale Club, Elevance Health, MGIC Investment, Mercer International and RCM Technologies
by Zacks Equity Research
BJ's Wholesale Club, Elevance Health, MGIC Investment, Mercer International and RCM Technologies are part of Zacks Screen of the Week article.
Encompass Health's (EHC) Future Hospital to Serve Pennsylvania
by Zacks Equity Research
Encompass Health (EHC) decides to develop a 50-bed inpatient rehabilitation hospital in Pennsylvania to better serve the rehabilitative needs of the local communities.
Centene (CNC) Wins Medi-Cal Contracts but Loses 3 Counties
by Zacks Equity Research
Centene (CNC) is likely to appeal the decision to avoid disruption in services and it has time until Sep 1, 2022, to do so.
Buy These 5 Stocks With Upgraded Broker Ratings Right Away
by Swayta Shah
As brokers have a deeper understanding of the stocks, one must follow rating upgrades. We pick BJ's Wholesale Club (BJ), Elevance Health (ELV), MGIC Investment (MTG), Mercer International (MERC) and RCM Technologies (RCMT) as these witness rating upgrades.
Humana (HUM) Brand to Open Senior-Centric Centers in Arizona
by Zacks Equity Research
Humana's (HUM) CenterWell brand announces plans to open nine centers by early 2023 to serve the aging population of the Phoenix region.
Looking for a Growth Stock? 3 Reasons Why Elevance Health (ELV) is a Solid Choice
by Zacks Equity Research
Elevance Health (ELV) possesses solid growth attributes, which could help it handily outperform the market.
Pediatrix (MD) Up 8% Since Q2 Earnings Release, Revenues Up Y/Y
by Zacks Equity Research
Pediatrix's (MD) second-quarter results reflect growth in patient volumes. Adjusted EBITDA is expected within $260-$270 million for 2022.
Cigna (CI) & Oscar Health Boost Presence in Philadelphia
by Zacks Equity Research
Cigna (CI) & Oscar Health's plans are likely to target businesses with 1-50 employees.
UnitedHealth (UNH) Unit Adds Features to Surest Plans
by Zacks Equity Research
UnitedHealth Group's (UNH) arm UnitedHealthcare advances Surest plans by including features to lure more employers into opting for the attractive package and bolster its geographic reach.
Are Medical Stocks Lagging Alkermes (ALKS) This Year?
by Zacks Equity Research
Here is how Alkermes (ALKS) and Elevance Health (ELV) have performed compared to their sector so far this year.
Ensign Group (ENSG) Stock Up 6% Since Q2 Earnings Release
by Zacks Equity Research
Ensign Group's (ENSG) second-quarter results reflect revenue growth, and solid contributions from the Skilled Services and Standard Bearer segments. A hiked 2022 EPS guidance bodes well.
Encompass Health (EHC) Up 4.7% Despite Q2 Earnings Miss
by Zacks Equity Research
Encompass Health (EHC) intends to open three additional de novo locations and increase the bed count by 20 in existing facilities this year.
ELV vs. GDRX: Which Stock Is the Better Value Option?
by Zacks Equity Research
ELV vs. GDRX: Which Stock Is the Better Value Option?
Community Health (CYH) Down 30.3% Since Q2 Earnings Report
by Zacks Equity Research
Community Health (CYH) expects capex to remain within $400-$450 million in 2022.
Teladoc (TDOC) Down 10.3% Despite Q2 Earnings & Sales Beat
by Zacks Equity Research
Teladoc (TDOC) projects total visits between 4.8 million and 5 million for the third quarter.
Humana (HUM) Q2 Earnings Beat Estimates, Ups '22 EPS View
by Zacks Equity Research
Humana's (HUM) second-quarter earnings benefit from higher premiums and strong individual Medicare Advantage membership growth. A hiked adjusted EPS guidance for 2022 is noteworthy.
3 Reasons Why Elevance Health (ELV) Is a Great Growth Stock
by Zacks Equity Research
Elevance Health (ELV) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ELV vs. GDRX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ELV vs. GDRX: Which Stock Is the Better Value Option?
Universal Health (UHS) Q2 Earnings Beat on Strong Segments
by Zacks Equity Research
Universal Health's (UHS) second-quarter results benefit from strong contributions from Acute Care Hospital Services and Behavioral Health Care Services segments, partly offset by elevated operating costs.
Has Elevance Health, Inc. (ELV) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Elevance Health (ELV) and HealthEquity (HQY) have performed compared to their sector so far this year.
Tenet Healthcare (THC) Q2 Earnings Beat, Trims '22 EPS View
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter earnings benefit from strong Ambulatory Care and Conifer segments. However, a trimmed EPS view for 2022 might raise concerns for investors.